Investment Rating - The report gives a "Buy" rating for the company, with a target price of HKD 9.73 based on a 27X valuation for 2026 [4]. Core Insights - The company, Saint Bella, is a leading global family care brand group, focusing on high-end postpartum care centers, family care services, and women's health foods, with plans to expand its store network significantly by 2025 [1][14]. - The postpartum care and recovery industry in China is projected to reach a market size of RMB 67.5 billion in 2024, indicating substantial growth potential and a shift towards premium services [2][37]. - The company has demonstrated strong financial performance, with a revenue of RMB 450 million in the first half of 2025, reflecting a year-on-year growth of 25.64%, and an adjusted net profit of RMB 39 million, up 126% [1][4]. Summary by Sections Company Overview - Saint Bella operates a multi-brand strategy with three main brands: "Saint Bella" for high-net-worth families, "Ai Yu" focusing on women's mental health, and "Little Bella" targeting younger markets [1][17]. - The company has expanded its presence internationally, with plans to double its store count in mainland China by 2030 and enter key global cities [3][14]. Industry Analysis - The postpartum care and recovery market is characterized by low penetration rates, suggesting significant room for growth and premiumization [2][37]. - The overall family care industry in China is expected to grow from RMB 392.8 billion in 2019 to RMB 805.3 billion by 2025, with a CAGR of 12.4% [37]. Competitive Advantages - The company leverages a light-asset model for rapid store expansion and has established a standardized care system supported by a team of leading experts [2][3]. - Its multi-brand strategy allows for clear brand positioning and different channel expansion paths, enhancing customer acquisition efficiency [2][3]. Future Development - The company aims to extend its service offerings to include postpartum recovery, family care, and elderly care, thereby maximizing customer lifetime value [3][4]. - Saint Bella is also focusing on integrating AI into its services, aiming to transform the traditional maternal and infant care industry [3][4]. Financial Projections - The company anticipates adjusted net profits of RMB 120 million, RMB 200 million, and RMB 298 million for 2025, 2026, and 2027, respectively, reflecting significant growth rates [4][5]. - Revenue is projected to reach RMB 1.85 billion by 2027, with a consistent growth trajectory across its business segments [5][20].

Investment Rating - The report assigns a "Buy" rating to the company with a target price of HKD 9.73 based on a 27X valuation for 2026 [4]. Core Insights - The company, Saint Bella, is a leading global family care brand group, focusing on high-end postpartum care centers, family care services, and women's health foods, with plans to expand its store network significantly by 2025 [1][3]. - The postpartum care and recovery industry in China is projected to reach a market size of RMB 67.5 billion in 2024, indicating substantial growth potential and a shift towards premium services [2][37]. - The company has demonstrated strong financial performance, with a revenue of RMB 450 million in the first half of 2025, reflecting a year-on-year growth of 25.64%, and an adjusted net profit of RMB 39 million, up 126% year-on-year [1][4]. Summary by Sections Company Overview - Saint Bella operates a multi-brand strategy with three main brands: "Saint Bella" for high-net-worth families, "Ai Yu" focusing on women's mental health, and "Little Bella" targeting younger markets [1][17]. - The company has expanded its presence internationally, with plans to double its store count in mainland China by 2030 and enter key global cities [3][14]. Industry Analysis - The postpartum care and recovery market is characterized by low penetration rates, indicating significant growth opportunities [2][37]. - The overall family care industry in China is expected to grow from RMB 392.8 billion in 2019 to RMB 805.3 billion by 2025, with a CAGR of 12.6% [37]. Competitive Advantages - The company leverages a light-asset model for rapid store expansion and has established a standardized care system supported by a team of leading experts [2][3]. - Its multi-brand strategy allows for clear brand positioning and different channel expansion paths, enhancing customer acquisition efficiency [2][3]. Future Development - The company aims to integrate AI into its services, targeting the trillion-dollar AI application market in the family care sector [3][4]. - Plans include expanding postpartum recovery and family care services to capture the full lifecycle value of customers [3][4]. Financial Projections - The company anticipates adjusted net profits of RMB 120 million, RMB 200 million, and RMB 298 million for 2025, 2026, and 2027, respectively, reflecting significant growth rates [4][5]. - Revenue is projected to reach RMB 1.85 billion by 2027, with a compound annual growth rate (CAGR) of 32.1% from 2025 to 2027 [5][4].

Investment Rating - The report assigns an "Outperform" rating to the company with a target price of HKD 6.8 [1] Core Insights - The company is expected to benefit from increasing foreign direct investment and a weakening US dollar, supported by its regulatory moat [1] - The projected compound annual growth rate (CAGR) for earnings from 2025 to 2027 is estimated at 12%, with approximately 30% of profits allocated for dividends [1] - The total capital expenditure for the NagaWorld Phase 3 project may be reduced by half from the original plan of USD 3.5 billion, with an expected payback period of about 4 to 5 years [1] - The company holds a monopoly on gaming operations within a 200-kilometer radius of Phnom Penh, Cambodia, until 2045, with a national gaming license expiring in 2065 [1] - The main visitors to NagaWorld are from Malaysia, Singapore, and China, and the growth in foreign direct investment and the depreciation of the US dollar are anticipated to drive earnings growth [1] - Cambodia has one of the lowest gaming tax rates globally, which supports the company's profitability, and the likelihood of a tax rate increase is considered low [1]

Investment Rating - The report maintains a target price of HKD 48.5 and rates the company as "Outperform" [1] Core Insights - WuXi Biologics (02269) has issued an earnings upgrade for the second half of 2025, with revenue expected to grow by 17% year-on-year, aligning with expectations, while net profit is projected to increase by 38% to RMB 2.6 billion [1] - Adjusted net profit is anticipated to rise by 31% to RMB 3.7 billion, significantly exceeding market expectations [1] - The gross profit margin is expected to increase by 6.2 percentage points to 48.8%, which is a key positive surprise in this earnings upgrade and the main driver behind the better-than-expected profit performance [1] - WuXi Biologics remains a preferred stock within the Chinese Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) sectors [1]

Investment Rating - The report upgrades ASMPT's rating from "Neutral" to "Overweight" and raises the target price from HKD 76 to HKD 125 [1] Core Insights - The upgrade is based on strong capital expenditure trends in the advanced logic packaging sector and initial signs of improvement in the mainstream outsourced semiconductor assembly and test (OSAT) market [1] - The bank has increased its earnings per share forecasts for ASMPT for the fiscal years 2026 and 2027 by 7% and 15%, respectively [1] - ASMPT is expected to raise its long-term total addressable market size for thermal compression bonding (TCB) equipment and shows confidence in gaining more market share in this area [1] - The company is set to provide further updates on its progress in the high bandwidth memory (HBM) thermal compression bonding market, noting that the capital expenditure environment in China and among mainstream OSAT vendors is becoming more favorable [1]

Investment Rating - The report maintains a "Buy" rating for SMIC (00981) with a target price of HKD 134, implying a projected P/E ratio of 71.6x for 2028. The target price for SMIC A-shares (688981.SH) is set at RMB 241.6, reflecting a 196% premium over the H-share valuation [1]. Core Insights - The report expresses a positive long-term outlook for SMIC, driven by increasing demand from domestic non-foundry customers and opportunities in AI [1]. - In Q4 of the previous year, SMIC's revenue increased by 4% quarter-on-quarter to USD 2.5 billion, exceeding both the bank's and market expectations by 3%, and surpassing management's guidance of 0% to 2% growth. The gross margin was 19%, aligning with management's guidance of 18% to 20% [1]. - Revenue growth was primarily attributed to a 1% increase in wafer shipments and average selling prices, while the gross margin decreased from 22% in the previous quarter due to higher depreciation and amortization expenses [1]. Management Guidance - For Q1 of this year, management expects revenue to remain flat quarter-on-quarter, which is in line with the bank's forecast of 2% growth and market expectations of flat revenue. The gross margin guidance for Q1 is maintained at 18% to 20%, slightly below the bank's expectation of 21.7% and market expectation of 20.9% [1]. - For the full year, management anticipates revenue growth to exceed the average level of comparable peers, with capital expenditures expected to remain flat year-on-year. The bank believes there is potential for upward revision in this guidance [1].

Investment Rating - The report maintains a "Buy" rating for Yum China (9987.HK) [5][15] Core Insights - The company reported a revenue of $2.823 billion for Q4 2025, a year-on-year increase of 9%, with operating profit rising by 25% to $187 million and net profit increasing by 24% to $140 million [5][6] - For the full year 2025, the company achieved a revenue of $11.797 billion, up 4% year-on-year, with operating profit of $1.29 billion, an 11% increase, and net profit of $929 million, a 2% increase [5][6] Summary by Sections Company Overview - Latest closing price: HKD 445.60 - Total shares: 354 million - Total market capitalization: HKD 1,578.99 billion - 52-week high/low: HKD 450.00 / HKD 363.80 - Debt-to-asset ratio: 42.21% - Price-to-earnings ratio: 22.05 [4] Financial Performance - Q4 2025 saw a same-store sales growth of 3%, marking the third consecutive quarter of growth, with same-store transaction volume increasing for twelve consecutive quarters [6][7] - The company added 587 new stores in Q4 2025, the highest for the quarter, with a 36% increase in franchise store ratio [7] - The restaurant profit margin for Q4 2025 was 13%, up 70 basis points year-on-year, while the operating profit margin was 6.6%, up 80 basis points [7][8] Growth Drivers - The company’s delivery sales grew by 34% year-on-year, accounting for 53% of restaurant revenue, up from 42% the previous year [8][11] - Membership numbers for KFC and Pizza Hut exceeded 590 million, with active members growing by 13% [8] Future Outlook - The company plans to add 1,900 new stores in 2026, aiming for over 20,000 total stores, with capital expenditures projected at $600-700 million [14] - Revenue growth is expected to be 6.3% in 2026, with net profit growth of 10.1% [15][17]

Investment Rating - The report maintains a "Buy" rating for NetEase Cloud Music (9899.HK) [5] Core Insights - The company reported 2025 revenue of RMB 7.759 billion, slightly below Bloomberg consensus of RMB 7.913 billion, with a year-over-year decline of 2.4% [1] - Gross profit reached RMB 2.770 billion, a 3.3% increase year-over-year, with a gross margin of 35.7%, slightly below the expected 36.4% [1] - Adjusted net profit attributable to shareholders was RMB 2.860 billion, a significant increase of 68.2% year-over-year, primarily due to the recognition of deferred tax assets [1] - The company is focusing on expanding its differentiated content ecosystem and enhancing product innovation through AI [3] Revenue and Profitability - Online music service revenue was RMB 5.994 billion, up 12.0% year-over-year, with subscription revenue increasing by 13.3% to RMB 5.053 billion [2] - Social entertainment services and other revenue decreased by 32.0% to RMB 1.765 billion, mainly due to the closure of the live streaming feature [2] - The company has seen growth in user scale and engagement, maintaining a DAU/MAU ratio above 30% [2] Content Strategy and Innovation - The company continues to strengthen its differentiated content ecosystem by deepening partnerships with domestic and international copyright holders, introducing K-POP labels, and enhancing its original content offerings [3] - The independent musician ecosystem has grown to over 1 million registered musicians, with more than 5.6 million tracks uploaded [3] - AI-driven product innovations, such as the Climber recommendation model and various interactive tools, have improved user experience [3] Cost Management - Sales expenses decreased by 33.2% to RMB 409 million, reflecting a more prudent approach to advertising and promotion [4] - Management and R&D expenses also saw slight reductions, contributing to overall cost control [4] Financial Forecasts - The adjusted net profit forecasts for 2026 and 2027 have been revised down to RMB 2.210 billion and RMB 2.467 billion, respectively, reflecting a 15% and 13% decrease from previous estimates [4] - The report anticipates a long-term improvement in profitability due to scale effects [4]

Investment Rating - The investment rating for the company is "Buy" [1] Core Views - The domestic milk powder market continues to face challenges, while overseas markets are expected to drive growth [3] - The company has experienced a decline in domestic sales due to a decrease in newborn population and competitive pressures, but there is optimism for recovery in 2026 [3] - The company is focusing on expanding its overseas market presence, particularly in the Middle East and North America, to create a diversified growth engine [3] Summary by Sections Company Overview - The company is identified as Ausnutria Dairy Corporation Ltd (1717.HK) with a market capitalization of HKD 34.70 billion [1] Market Trends - In 2025, the birth rate in China dropped to 5.63‰, with a total of 7.92 million newborns, reflecting a 17% year-on-year decline [2] - The domestic milk powder industry is experiencing intense competition, with only a few brands like Yili, Biostime, and Mengniu showing growth [2] Financial Performance - The company's revenue forecast for 2025-2027 has been revised down from HKD 78.3 billion to HKD 74.9 billion for 2025, with net profit estimates also reduced [5] - The earnings per share (EPS) forecast for 2025-2027 has been adjusted from HKD 0.17 to HKD 0.13 for 2025 [5] Growth Strategies - The company aims to enhance its product offerings and market presence through strategic initiatives, including channel expansion and product innovation [4] - The approval of a new probiotic strain for infant use marks a significant milestone for the company, reinforcing its technological capabilities [4] Financial Projections - The projected revenue for 2025 is HKD 74.9 billion, with a net profit of HKD 2.4 billion, reflecting a decrease from previous estimates [5] - The company expects to achieve a net profit margin of approximately 3.19% in 2024, with gradual improvements in subsequent years [8]

Investment Rating - The investment rating for Tianli International Holdings (01773.HK) is "Outperform the Market" (maintained) [2][16]. Core Views - The company is strategically expanding its enrollment of transfer students to counteract the previous slowdown in enrollment growth, with a target of approximately 7,000 transfer students for the fiscal year 2026, which is expected to increase the total number of students served by about 14% year-on-year [3][5]. - The AI education products are showing sustained effectiveness, accelerating revenue conversion. The AI Sprint Camp has reached 1,934 students as of January 26, 2026, with expectations to exceed 4,000 students for the year, projecting revenues of 0.88 billion, 1.54 billion, and 2.31 billion for FY2026, FY2027, and FY2028 respectively [3][8][11]. - The company forecasts revenues of 39.15 billion, 42.25 billion, and 44.99 billion for FY2026, FY2027, and FY2028, with corresponding growth rates of 9.1%, 7.9%, and 6.5%. Adjusted net profits are projected to be 7.41 billion, 8.21 billion, and 9.01 billion for the same periods, with growth rates of 11.5%, 10.9%, and 9.7% [3][16]. Summary by Sections Enrollment Strategy - The company is actively adjusting its enrollment strategy to address the short-term negative impact on enrollment growth. As of January 25, 2026, 3,603 transfer students have been enrolled, with a projected total of 14.8 million students served in FY2026, reflecting a year-on-year increase of approximately 14% [3][5]. - The strategy includes a slight relaxation of enrollment standards to increase student reserves while maintaining teaching quality [7]. AI Education Business - The AI Sprint Camp business is accelerating its commercialization, with expected revenue conversion of 0.88 billion for FY2026. The program has shown significant improvement in student performance, with a notable increase in the number of students covered [8][10]. - The AI system, developed by the company's subsidiary, aims to enhance educational outcomes, particularly for students who are lagging behind [10]. Share Buyback and Investor Confidence - The company announced a share buyback plan, intending to repurchase up to 200 million HKD worth of shares in the open market, which is expected to enhance investor confidence [3][12].